CDKN2A and acquired factor X deficiency: A frequent driver gene evidenced in both subgroups was CDKN2A (cyclin-dependent kinase inhibitor 2A) gene loss or inactivating mutation, present in six (60%) AFX and 11 (85%) PDS samples (Figure 4b).